Eledon Pharmaceuticals, Inc. Common Stock (NASDAQ: ELDN) last traded at $2.34, down 4.10% on the session. The quote above updates while this page is open; the figures below are drawn from Eledon Pharmaceuticals, Inc. Common Stock’s own filings and are restated only when a new one is published.
Eledon Pharmaceuticals, Inc. Common Stock trades on NASDAQ under the ticker ELDN. Its market capitalisation is $190.15 million.
Valuation measures for Eledon Pharmaceuticals, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $190.15M |
|---|---|
| Enterprise value | $237.41M |
| Price / book | 5.76 |
| Beta | 1.80 |
Trailing-twelve-month figures tagged in Eledon Pharmaceuticals, Inc. Common Stock's XBRL filings with the SEC.
| Net income (TTM) |
|---|
| -$98.56M |
| EPS (TTM) | -$0.910 |
|---|
| Return on equity | -298.55% |
|---|
| Cash | $6.80M |
|---|
Range and volume for ELDN over the past 52 weeks.
| 52-week high | $4.60 |
|---|---|
| 52-week low | $1.35 |
| Volume | 1.17M |
| Average volume | 922.4K |
| Previous close | $2.44 |
Invest a chosen dollar amount in Eledon Pharmaceuticals, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell ELDN.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.